
Brain Space is modernizing neurocritical care and cerebrospinal fluid management by automating treatment and generating novel data. They have developed an automated cerebrospinal fluid (CSF) manager that offers single-drop drainage control while preserving the gravity-based approach trusted by neurosurgeons. This innovative solution combines precision drainage and continuous intracranial pressure (ICP) monitoring, allowing ICU doctors and nurses to optimize patient care. The system also automates nurse workload, reduces complexity, and generates AI-ready data, facilitating new clinical studies. Brain Space aims to improve patient mobility and reduce the risks associated with existing high-risk, labor-intensive options used in hospitals today.

Brain Space is modernizing neurocritical care and cerebrospinal fluid management by automating treatment and generating novel data. They have developed an automated cerebrospinal fluid (CSF) manager that offers single-drop drainage control while preserving the gravity-based approach trusted by neurosurgeons. This innovative solution combines precision drainage and continuous intracranial pressure (ICP) monitoring, allowing ICU doctors and nurses to optimize patient care. The system also automates nurse workload, reduces complexity, and generates AI-ready data, facilitating new clinical studies. Brain Space aims to improve patient mobility and reduce the risks associated with existing high-risk, labor-intensive options used in hospitals today.
Product: Intellidrop — FDA-cleared bedside system for automated CSF drainage and ICP monitoring
Team size: 16 employees
Tech focus: Closed-loop automation, continuous sensing, single-drop gravity-based drainage, AI-ready data
Funding (reported): Total funding listed as 5,180,000 USD; last funding date 2024-05-29
Neurocritical care; cerebrospinal fluid (CSF) drainage and intracranial pressure (ICP) monitoring
Medical devices; MedTech
5180000.00 USD